HRMY - Harmony Biosciences Holdings Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-08-05    (Delayed quote data   2025-07-09)
Last
 34.29		 Change
 ⇑ +1.54   (+4.70%)		 Volume
  511,831
Open
 33.07		 High
 34.36		 Low
 33.07
8EMA (Daily)
 32.72		 40EMA (Daily)
 32.94		 50EMA (Daily)
 32.97		 STO (Daily)
 51.708		 MACD Hist (Daily)
 0.357
8EMA (Weekly)
 33.089		 40EMA (Weekly)
 33.50		 50EMA (Weekly)
 33.59		 STO (Weekly)
 61.880		 MACD Hist (Weekly)
 0.195
Company Profile
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com